Study of eye implant for inflammatory eye disease
Part of Eyes & vision clinical trials.
This trial looks at how often inflammatory flare-ups happen in patients with a type of eye inflammation called posterior uveitis. It focuses on people who have been treated with a fluocinolone acetonide implant, a tiny device placed in the eye that releases medicine over time, and aims to understand how well it controls inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with non-infectious uveitis (eye inflammation not caused by an infection) that affects the back part of your eye
- You have swelling in the center of your retina (macular edema) or ongoing inflammation in the back of your eye
- You received a fluocinolone acetonide implant in your eye before January 2024
- Your doctor is able to follow up with you for at least 12 months after the implant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses two special eye scans (OCT and OCT angiography) to look at the back part of the eye in people with posterior uveitis. The goal is to better understand and monitor this type of eye inflammation.
This study tests whether receiving two YUTIQ injections works better than a sham (fake) treatment for long-lasting inflammation inside the back part of the eye. It is meant to reduce ongoing “posterior segment” inflammation and improve comfort and eye health when prior steroid treatments have helped but the inflammation keeps coming back.
This trial tests an eye implant (ILUVIEN) in children and teens ages 6 to 17 who have a type of eye inflammation called uveitis that keeps coming back. The implant releases medicine slowly over time to control inflammation and may help reduce the need for other treatments.
This study follows adults with non-infectious uveitis (intermediate, posterior, or pan-uveitis) to better understand inflammation activity and treatment needs. It also follows adults having planned eye surgery (like cataract or vitreoretinal surgery) to compare groups.
This trial tests a new eye drop (tacrolimus) to treat non-infectious anterior uveitis, an inflammation in the front part of the eye. It may help reduce the need for steroid eye drops.
This study uses a special eye scan (OCT) to measure and classify inflammatory cells inside the eye. It aims to better understand different types of uveitis and improve diagnosis and treatment.
Hear when a new Uveitis, Posterior trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.